In-solution digestion of proteins and enrichment of lysine acetylated peptides
The precipitated proteins were re-dissolved in 6M urea/2M thiourea/10mM HEPES pH 8.0. For extracting proteins from the RIPA insoluble pellet, the pellets were dissolved in 8M Urea/thiourea after digesting the DNA with Benzonase (Merck). Protein disulfide bonds were reduced by 1 mM dithiothreitol, alkylated with 5.5 mM iodoacetamide, digested using endoproteinase Lys-C (1:100 w/w) and modified sequencing grade trypsin (1:100 w/w) after 4-fold dilution in deionzied water, as described previously (Olsen et al., 2006) . The resulting peptides were purified using reversed-phase Sep-Pak C 18 peptide purification cartridges. The purified peptides were eluted using 50 percent acetonitrile. The eluates were lyophilized over night and lyophilized peptides were redissolved in the immunoprecipitation buffer (50 mM MOPS pH 7.2, 10 mM Sodium phosphate, 50 mM Sodium chloride) and incubated with anti-acetyllysine antibody for 12
hrs at 4 o C on a rotation wheel. The immunoprecipitates were washed 4 times with the immunoprecipitation buffer followed by two washes with distilled water. Residual water was removed and acetylated peptides bound to antibodies were eluted by acidified water (0.1% TFA in water).
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Isoelectric focusing of peptides
The eluted lysine acetylated peptides were separated into 12 fractions by iso-electric focusing (IEF) using the Agilent 3100 OFFGEL Fractionator (Agilent, G3100AA) and the 3100 OFFGEL High Res kit, pH 3-10 (Agilent, 5188-6424) according to the manufacturer's instructions as described (Hubner et al., 2008) . Briefly, peptides were focused for 50 kilovolt hours at a maximum current of 50 µA and maximum power of 200 milliwatts. Peptide fractions were acidified by adding 10 µL of a solution containing 30% acetonitrile, 10% trifluoroacetic. The samples were StageTipped as described (Rappsilber et al., 2007) .
Mass spectrometric analysis
The peptides were eluted from StageTips and analyzed by online nanoflow liquid chromatography tandem mass spectrometry (LC-MS/MS) as described previously (Olsen et al., 2006 ) with a few modifications. All nanoLC-MS/MS-experiments were performed on a Agilent Technologies 1200 nanoflow system connected to the LTQOrbitrap XL (Thermo Electron, Bremen, Germany) equipped with a nanoelectrospray ion source (Proxeon Biosystems, Odense, Denmark) as described (Olsen et al., 2005) .
Briefly, the LTQ Orbitrap XL instrument (Olsen et al., 2007) under Xcalibur 2.0 with LTQ Orbitrap Tune Plus Developers Kit version 2.0 software was operated in the data dependent mode to automatically switch between MS and MS/MS acquisition. Survey full scan MS spectra (from m/z 300 -2000) were acquired in the orbitrap with resolution R=60,000 at m/z 400 (after accumulation to a "target value" of 1,000,000 in the linear ion trap). The ten most intense ions were sequentially isolated and fragmented in the linear ion trap by collisionally induced dissociation (CID) at a target value of 5,000 or maximum ion time of 150 ms. For all measurements with the orbitrap detector a lockmass ion from ambient air (m/z 429.08875) was used for internal calibration as described earlier (Olsen et al., 2005) . Typical mass spectrometric conditions were: spray voltage, 2.2 kV; no sheath and auxiliary gas flow; heated capillary temperature, 175ºC; normalized CID collision energy 35% for MS2 in LTQ. The ion selection threshold was 500 counts for MS2. An activation q = 0.25 and activation time of 30 ms were used. 
Data analysis
The resulting Mascot html-output files were loaded into the MaxQuant software for further processing. In MaxQuant we fixed the estimated false discovery rate (FDR) of all peptide and protein identifications at maximum 1%, by filtering on peptide length, mass error and mascot score of all forward and reversed peptide identifications. From these only peptides with at least one internal acetylated lysine residue and minimum mascot score of 10 were accepted. Finally, to pinpoint the actual acetylated amino acid residue within the identified peptide sequence in an unbiased manner, we calculated the localization probabilities of all lysine acetylation sites using the PTM score algorithm as described (Olsen et al., 2006) .
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Acetylation site overlap between cell lines
For the six separate experiments (two each for MV4-11, A549 and Jurkat) we calculated the overlap of each versus all others, and calculated two metrics. (a) Overlap of the two data sets as the percent of the smaller of two data sets:
and, (b) Jaccard similarity coefficient(scaled to [0,100]) as defined below:
Phylogenetic conservation analysis
To compare the degree of conservation of genes that encode acetylated proteins with the genes that do not encode acetylated proteins, we first mapped our identified peptides to gene transcripts annotated in EnsEMBL (Flicek et al., 2008) as described in MAPU 2.0 (Gnad et al., 2008) . We used the EnsEMBL Compara Database, which contains phylogenetic relationships throughout eukaryotic species and cover the phylogenetic tree representatively. To avoid a possible bias for high abundant proteins in our dataset, we chose only those genes that are annotated as "known" in the EnsEMBL database.
Pfam protein domain enrichment analysis
For the identified IPI protein entries the Pfam domain (Finn et al., 2008) enrichment analysis was done with respect to the whole IPI human proteome by hypergeometric test available in the GOstats package (Falcon and Gentleman, 2007) in the R statistical environment (Team, 2008) . All domains with p-val < 10 -5 were considered significant.
The analysis was done separately for over and under represented Pfam domains.
CORUM complex enrichment analysis
Protein complex annotations for human dataset were downloaded from CORUM database (Ruepp et al., 2008) Network analysis for the acetylome. The IPI identifiers of our acetylation study were mapped to the Ensemble protein identifiers (2,142 in total), and then searched against the STRING database version8 (Jensen et al., 2008) for protein-protein interactions.
Only interactions between the proteins belonging to the acetylation dataset were selected. STRING defines a metric called "confidence score" to define interaction confidence; we fetched all interactions for our acetylation dataset which had a confidence score ≥ 0.7 (high confidence). The resulting interactome had 1,011 nodes and 5,999 interactions which we call the acetylation interaction network (AIN) ( Figure   S6A ).
MCODE based node cluster analysis
The acetylation interaction network (AIN) was analyzed for densely connected regions using a graph theoretic clustering algorithm -"Molecular Complex Detection" (MCODE) (Bader and Hogue, 2003) . MCODE is part of the plug-in toolkit of network analysis and visualization software Cytoscape (Shannon et al., 2003) . The first 7 high ranking modules were selected for further analysis and rendering ( Figure S6B ).
Network significance analysis
In order to ascertain the significance of the total connectivity of our AIN we employed a bootstrapping procedure to compare AIN connectivity to those of randomly sampled networks generated from STRING across 1,000,000 iterations. Firstly, we filtered the STRING version8 human interactome to include only interactions which had a confidence score ≥ 0.7, which we call Human high confidence network (HHCN The significance of AIN connectivity was calculated by the following formula:
We found our acetylome interaction network to have a connectivity significance of p-val < 10 -6 ( Figure S5 ).
Yeast (Saccharomyces cerevisiae) strains:
Genomic deletions in diploid W303 (ura3 trp1 leu2 his3 ade2 can1-100) were generated by PCR-mediated genomic integration of the natNT2 marker (Janke et al., 2004) . For plasmid shuffle experiments, more than ten independent transformants for each plasmid were tested. 
Yeast strains list:
Acetylation mapping of yeast Cdc28
To investigate acetylation of S. cerevisiae Cdc28 we used a C-terminal GFP tagged
Cdc28 strain (Huh et al., 2003) . Total protein lysate was prepared by bead milling in a buffer containing 150mM potassium acetate, 20mM HEPES pH 7.4, 5% Glycerol.
Subsequently TritonX-100 was added to a final concentration of one percent and 8 lysates were clarified by two consecutive spins of 5 minutes at 2000g. Cdc28-GFP was immunoprecipitated using a GFP-trap matrix and immunoprecipitates were washed 5X using the lysis buffer. Proteins were eluted by boiling the beads in SDS-PAGE gel loading buffer and separated on 1D gel, gel pieces were excised near the expected molecular weight of Cdc28-GFP. Peptides were recovered after in-gel trypsin digestion (Shevchenko et al., 1996) . The resulting peptides were Stage-tipped and analyzed by LC-MS/MS as described above.
Plasmid constructs and site directed mutagenesis
The plasmid encoding human 14-3-3 epsilon fused to GST on N-terminal (pGEX-KG-GST-14-3-3 epsilon) was a kind gift from Dr. Justus Duyster (Urschel et al., 2005) , and pBCHGN-CBX3 was a kind gift from Tom Misteli (Cheutin et al., 2003) . To generate pRS316-CDC28 and pRS314-CDC28, the promoter and open reading frame of CDC28 was amplified using primers 5" -TATGGATCCTTCCCTTACTGGGCGCACGCAGT and 3" ATAGAATTCAATTATGATTCTTGGAAGTAGGG and cloned into the EcoRI and BamHI sites of pRS316 or pRS314, respectively (Sikorski and Hieter, 1989) .
Mutagenesis on human 14-3-3 epsilon and yeast CDC28 were performed using site directed mutagenesis kit (Stratagene) following manufacturer"s instructions. Integrity of the mutant plasmids was verified by DNA sequencing.
Lysate preparation for Western blotting
Total cell extract from Hela or U2OS BAC transgenic cell lines expressing GFP-tagged transgenes was prepared using high salt RIPA lysis buffer containing 420 mM NaCl.
Lysates were rotated at 4 o C for 60 minutes. Thereafter, lysates were sonicated and cleared by centrifugation (16,000g for 15 minutes). For immunoprecipitation, cell lysates were incubated with 25 µL of GFP-trap matrix (Chromoteck), at 4 o C overnight.
Immunoprecipitates were washed five times using lysis buffer. Proteins bound to beads were eluted by boiling beads in gel loading buffer. Proteins were separated on SDS-PAGE and transferred on to PVDF membrane and probed using anti-GST or antiacetyllysine antibodies.
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Transfection of HEK293 cells
For transient overexpression of CBX3, HEK293 cells were transfected using Lipofectamine and Plus reagents (Invitrogen), following manufacturer"s instructions.
Thirty six hours after transfection, cells were trypsinized, washed twice with PBS, and lysed as described above.
Peptide synthesis and peptide pull-down
Phosphorylated and unphosphorylated peptide sequences of RAF-1 (LSQRQRSTpSTPNVHMV) and KIF1c (RRQRpSAP) containing a desthio-biotinylated amino-group on the N-terminus, and a Serine-Glycine (SG) spacer, were synthesized using the Fmoc strategy as described (Schulze and Mann, 2004) . Peptides were immobilized on to streptavidin sepharose beads (GE Healthcare) and subsequently incubated with 2 μg of recombinant GST-14-3-3 for 2 hr at 4°C on a rotational wheel.
Beads were washed five times with 1 ml of RIPA lysis buffer. Bound proteins were eluted by boiling beads in SDS, and eluted proteins were separated on 4%-12% gradient gels (Invitrogen), and stained using colloidal Coomassie blue staining kit (Invitrogen).
Preparation of recombinant GST-14-3-3
Recombinant GST-tagged 14-3-3 epsilon and its different mutants were expressed in E.
coli BL21 cells. For expression of the recombinant protein cultures were grown at 30 degrees, and expression of the fusion protein was induced for 3 hours using 1 mM
Isopropyl β-D-1-thiogalactopyranoside (IPTG). Bacterial cultures were resuspended in lysis buffer 20mM Triethanolamine (TEA)-HCL, 150 mM NaCl, 10 mM EDTA, 1 mM PMSF, 0.5% Triton-X100, and 0.1% β-mercaptoethanol. Lysates were sonicated and cleared by centrifugation. Cleared lysates were incubated with GST-sepharose beads overnight. Thereafter, beads were washed four times using GST wash buffers. Finally, beads were collected as 50% slurry. GST-14-3-3 was eluted from beads using 10 mM glutathione.
GST-pull-down and in-gel digestion
To identify proteins that interact with 14-3-3 and its mutants, 500 µg of cell extracts from SILAC-labeled (´light´or ´heavy´) MV4-11 cells were incubated with different GST-14-3-3 mutants immobilized on to sepharose beads and incubated 3 hours at 4 o C.
Thereafter, beads were washed five times with RIPA lysis buffer and proteins bound to these beads were eluted using 8M urea and separated on 4-12% gradient SDS-PAGE, and stained using colloidal blue Coomassie staining. In-gel digestion of proteins and recovery of peptides were performed as described earlier (Shevchenko et al., 2006; Shevchenko et al., 1996) . Eluted peptides were stage-tipped (Rappsilber et al., 2007) and analyzed by mass spectrometry. all seven human 14-3-3 isoforms were aligned using the ClustalW2 algorithm (Larkin et al., 2007) . The lysines highlighted in red are acetylated in at least two different isoforms.
Asterisks mark lysines that are acetylated in multiple 14-3-3s and are conserved across all seven isoforms. (B) Multiple 14-3-3 isoforms are acetylated in-vivo. Some of the peptides sequences are not unique to specific 14-3-3 isoform but match to multiple isoforms. Figure S9 . Schematic presentation of GST-14-3-3 pull-down experiment. GST-14-3-3 epsilon or its mutants were incubated with cell lysates prepared from MV4-11 cells labeled with "light" or "heavy" SILAC. In the forward experiment, 14-3-3 epsilon wild-type was incubated with "heavy" and mutant 14-3-3 with "light" SILAC lysates. The specific interactors that bind more strongly to 14-3-3 compared to the mutant show higher peptide intensity in their heavy forms in the SILAC pair. In a reverse experiment the SILAC label was swapped and 14-3-3 wild-type was incubated with "light" and mutant 14-3-3 with "heavy" labeled SILAC. This results in the reversal of SILAC ratios for proteins that interact more strongly with 14-3-3 compared to the mutants.
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Supplementary Tables: Supplementary Table S1 List of all acetylation sites identified from MV4-11, Jurkat, and A549 cells. For description of columns see Online Materials and Methods. Acetylated proteins and sites were classified into different biological categories and are given in different sheets in the Excel table.
Supplementary Table S2
Acetylated proteins are present in large protein complexes. Enrichment of acetylated proteins in known mammalian protein complexes was analyzed using CORUM. This table list the protein complexes obtained from CORUM database, whose components were found to be significantly enriched in our acetylation dataset (over-represented, pvalue <0.05). Complexes that were significantly acetylated were retained (p < 0.05).
These complexes were further categorized based on their cellular localization (Nuclear, Cytoplasmic, Mitochondria, Others) as provided by CORUM annotations (Ruepp et al., 2008) .
Supplementary Table S3
List of proteins that interact with 14-3-3 in an acetylation dependent manner. Proteins that interact strongly with 14-3-3 compared to its acetylation mimetic mutants (K50Q, or K118+123Q, or K50+K118+K123Q) were identified and quantified by SILAC-based 14-3-3 GST-pull down experiments as described in Fig. S9 .
Supplementary Table S4
List of acetylation sites quantified in response to SAHA or MS-275.
Supplementary Table S5.
Acetylation sites upregulated by SAHA and MS-275 in MV4-11 cells. Acetylation changes of peptides upon inhibitor treatments were quantified as described in the supporting online material. Peptides with >2 fold increase in acetylation in response to both inhibitors are listed. 
Kyoto Encyclopedia of Genes and Genomes pathway names
KEGG Pathway orthologs
Kyoto Encyclopedia of Genes and Genomes pathway orthologs
Localization Prob
Localization probability of acetylation site assignment to a specific lysine in the identified peptide based on the PTM score Score Diff Delta PTM score between highest scoring acetylated site assignment and second highest scoring
Number of Acetyl (K)
Number of lysine acetylated residues present on the identified lysine acetylated peptide Amino Acid Amino acid that is acetylated i.e Lysine Sequence Window A 13 amino acid sequence sequence showing 6 amino acid flanking each side of lysine acetylated site
Mascot Score
Peptide ion MS/MS Probability-based Mowse score from Matrix Science: Mowse score = -10xLog 10 (p), where p is the likelihood that the identification is a random event PTM Score Probability-based phosphosite localization score based on the binominal distribution score: PTM score = -10xLog 10 (p), where p is the likelihood that the identification is a random event Modified Sequence Acetylated peptide sequence and modifications of amino acids on this peptide sequence that were identified by mass spectrometer; M(ox) = oxidized methionine, ac = N-Protein acetylated residue, K(ac) = acetylated residue.
Acetyl (K) Probabilities
Localization probability of acetylation site assignment to specific lysines in the identified peptide based on the PTM score 
SILAC Ratio of acetylated peptide intensities for cells treated with MS-275 versus control cells treated with DMSO
Abbreviations:
Explanation: Ctrl.
Control
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Bader, G. --MEKTELIQKAKLAEQAERYDDMATCMKAVTEQGAELSNEERNLLSVAYKNVVGGRRSA 58 14-3-3_sigma --MERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAA 58 14-3-3_eta -MGDREQLLQRARLAEQAERYDDMASAMKAVTELNEPLSNEDRNLLSVAYKNVVGARRSS 59 14-3-3_gamma -MVDREQLVQKARLAEQAERYDDMAAAMKNVTELNEPLSNEERNLLSVAYKNVVGARRSS 59 14-3-3_epsilon -MDDREDLVYQAKLAEQAERYDEMVESMKKVAGMDVELTVEERNLLSVAYKNVIGARRAS 59
14-3-3_zeta/delta WRVVSSIEQKT--EGAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNASQA--ES 114 14-3-3_beta/alpha WRVISSIEQKT--ERNEKKQQMGKEYREKIEAELQDICNDVLELLDKYLIPNATQP--ES 116 14-3-3_theta
WRVISSIEQKT--DTSDKKLQLIKDYREKVESELRSICTTVLELLDKYLIANATNP--ES 114 14-3-3_sigma WRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDA--ES 116 14-3-3_eta WRVISSIEQKTMADGNEKKLEKVKAYREKIEKELETVCNDVLSLLDKFLIKNCNDFQYES 119 14-3-3_gamma WRVISSIEQKTSADGNEKKIEMVRAYREKIEKELEAVCQDVLSLLDNYLIKNCSETQYES 119 14-3-3_epsilon WRIISSIEQKEENKGGEDKLKMIREYRQMVETELKLICCDILDVLDKHLIPAANTG--ES 117
14-3-3_zeta/delta KVFYLKMKGDYYRYLAEVAAGDDKKGIVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNF 174 14-3-3_beta/alpha KVFYLKMKGDYFRYLSEVASGDNKQTTVSNSQQAYQEAFEISKKEMQPTHPIRLGLALNF 176 14-3-3_theta KVFYLKMKGDYFRYLAEVACGDDRKQTIDNSQGAYQEAFDISKKEMQPTHPIRLGLALNF 174 14-3-3_sigma RVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNF 176 14-3-3_eta KVFYLKMKGDYYRYLAEVASGEKKNSVVEASEAAYKEAFEISKEQMQPTHPIRLGLALNF 179 14-3-3_gamma KVFYLKMKGDYYRYLAEVATGEKRATVVESSEKAYSEAHEISKEHMQPTHPIRLGLALNY 179 14-3-3_epsilon KVFYYKMKGDYHRYLAEFATGNDRKEAAENSLVAYKAASDIAMTELPPTHPIRLGLALNF 177
14-3-3_zeta/delta SVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEESYKDSTLIMQLLRDNLTLWTSDTQG 234 14-3-3_beta/alpha SVFYYEILNSPEKACSLAKTAFDEAIAELDTLNEESYKDSTLIMQLLRDNLTLWTSENQG 236 14-3-3_theta SVFYYEILNNPELACTLAKTAFDEAIAELDTLNEDSYKDSTLIMQLLRDNLTLWTSDSAG 234 14-3-3_sigma SVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWTADNAG 236 14-3-3_eta SVFYYEIQNAPEQACLLAKQAFDDAIAELDTLNEDSYKDSTLIMQLLRDNLTLWTSDQQD 239 14-3-3_gamma SVFYYEIQNAPEQACHLAKTAFDDAIAELDTLNEDSYKDSTLIMQLLRDNLTLWTSDQQD 239 14-3-3_epsilon SVFYYEILNSPDRACRLAKAAFDDAIAELDTLSEESYKDSTLIMQLLRDNLTLWTSDMQG 237
14-3-3_zeta/delta ---DEA-EAGEGGEN---245 14-3-3_beta/alpha ---DEG-DAGEG------244 14-3-3_theta ---EEC-DAAEGAEN---245 14-3-3_sigma ---EEGGEAPQEPQSEN-250 14-3-3_eta ---EEA---GEGN-----246 14-3-3_gamma ---DDG---GEGNN----247 14-3-3_epsilon DGEEQNKEALQDVEDENQ 255
Modified pepƟde sequence 14-3-3 isoform (Ac-K) 
Figure_S9
Supplementary Table S3 Gene Names Ratio 14-3-3-WT/14-3-3-K50Q Ratio 14-3-3-K50Q/14-3-3-WT Ratio 14-3-3-WT/14-3-3-K118+K123Q 
